Table 2.

Immunofluorescence Flow Cytometric Analysis of MSCV-FL Leukemic Cells for Coexpression of B-Lymphoid and Myeloid Cell Surface Antigens

Cell Surface Antigen
B220Mac-1B220/Mac-1
Leukemic cells 
 SPL196 (4°) 78 3.8 2.4 
 SPL196 (3°, cultured) 19 10 1.3 
 SPL199 (5°) 42 15 14 
 SPL199 (4°, cultured) 6.5 74 2.1 
 SPL203 (3°) 17 30 12 
 SPL203 (2°, cultured) 0.6 57 0.8 
 SPL204 (3°) 86 1.8 7.8 
 SPL204 (2°, cultured) 4.5 2.3 93 
 BALB/c SPL 32 5.1 2.3 
Cell Surface Antigen
B220Mac-1B220/Mac-1
Leukemic cells 
 SPL196 (4°) 78 3.8 2.4 
 SPL196 (3°, cultured) 19 10 1.3 
 SPL199 (5°) 42 15 14 
 SPL199 (4°, cultured) 6.5 74 2.1 
 SPL203 (3°) 17 30 12 
 SPL203 (2°, cultured) 0.6 57 0.8 
 SPL204 (3°) 86 1.8 7.8 
 SPL204 (2°, cultured) 4.5 2.3 93 
 BALB/c SPL 32 5.1 2.3 

Results are the percentages of labeled leukemic spleen (SPL) cells determined by direct staining of FcγRII/III-blocked cells with phycoerythrin-conjugated anti-B220 and fluorescein isothiocyanate-conjugated anti–Mac-1 monoclonal antibodies (as described in Materials and Methods); ≤ 2%, background staining. Spleen cells (5 × 106) were serially transplanted by intravenous injection into recipients that had received 4 Gy of γ-irradiation. Two weeks posttransplantation, single-cell suspensions were prepared from enlarged spleens and analyzed directly or transferred to liquid culture and maintained in the presence of KL, IL-3, and IL-7 plus G418 for 2 to 3 weeks before analysis.

or Create an Account

Close Modal
Close Modal